MIRANDA TEDDER: Open Payments
NPI 1023650868 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 7 payments from 6 companies in 2025. Trend: 2023 $5,500 · 2024 $1,551 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| ABBVIE INC. | 1 | $105 |
Products named: CAPLYTA, Kerendia, FANAPT, FARXIGA, Wegovy, VRAYLAR, Ozempic.
Industry payments across IN — which companies pay providers there.
